New discovery sheds light on 'deadly' cell death process linked to cancer and neurodegenerative diseases

1 min read

The Deletion of Phosphoglycolate Phosphatase Drives a Metabolic Rewiring that Inhibits Ferroptosis

In this study, researchers modulated ferroptosis, a form of cell death driven by uncontrolled lipid peroxidation, as it is of interest in numerous diseases. The deletion of phosphoglycolate phosphatase (PGP), an essential enzyme that safeguards high glycolytic flux, was found to suppress ferroptosis. This suppression was achieved through a rewiring of the pentose phosphate pathway and cellular energy and lipid metabolism.

The researchers used metabolomic and isotopic labeling experiments together with lipid and proteomic profiling to investigate the effects of PGP loss on cellular metabolism. These studies revealed that PGP deletion drives a multifactorial antioxidant response. Notably, pharmacological inhibition of PGP using a compound known as CP1 led to unexpected results.

Further characterization of CP1 was conducted using genetic, biochemical, and biophysical approaches. It was found that CP1 is a direct inhibitor of phosphoglycolate phosphatase (PGP) and ferroptosis suppressor protein 1 (FSP1). Additionally, CP1 triggers FSP1 self-assembly.

The identification of PGP as a target protein for ferroptosis control has significant implications. The introduction of a small-molecule FSP1 inhibitor with unique features offers new opportunities for pharmacological modulation of ferroptosis. This finding underscores the complex interplay between metabolic pathways and cell death mechanisms, highlighting the potential for targeting specific enzymes to modulate disease outcomes.

1 min read

In the intricate dance of life, cells must balance their energy and lipid production to survive. But when this delicate balance is disrupted, cells can die from a process called ferroptosis - a form of cell death that occurs when uncontrolled lipid peroxidation takes hold. For many diseases, understanding how to modulate ferroptosis is crucial.

In this groundbreaking research, the team discovered that deleting an essential enzyme called phosphoglycolate phosphatase (PGP) suppresses ferroptosis. But what's surprising is that PGP's absence triggers a complex response in the cell, rewiring its energy and lipid metabolism pathways. To understand why, the researchers turned to a compound called CP1, which initially seemed like it might help control ferroptosis - but ended up having the opposite effect. Instead, they found that CP1 acts as a double agent, inhibiting both PGP and another protein called FSP1.

This finding opens doors for developing new treatments for diseases where ferroptosis plays a role. By targeting PGP and introducing a small-molecule inhibitor of FSP1, the researchers have created a novel approach to modulating ferroptosis - one that holds promise for treating conditions such as cancer, neurodegenerative disorders, and more. This discovery highlights the importance of understanding the intricate relationships within cells and how manipulating these pathways can lead to new therapeutic opportunities.

1 min read

Imagine your cells are like a city, with different neighborhoods working together to keep everything running smoothly. One of those neighborhoods is called the "pentose phosphate pathway," which helps make energy for the cell. But sometimes, like when there's too much pollution in the air, this neighborhood can get out of control and start causing damage.

Researchers Brenner M et al. discovered that if a key enzyme called phosphoglycolate phosphatase is turned off, it actually helps calm down this damaged neighborhood. This led to a surprising finding: a special compound called CP1, which was meant to help fix the problem, ended up making things worse. Instead, the researchers found a way to create a new tool that can target and turn off another key player in the process. It's like finding a way to clear the air and get the city's energy production back on track – it's a big step forward in understanding how our cells work.